Adjustments for Non-Cash Items (USD, millions)

Stock-Based Compensation (USD, millions)

Changes in Working Capital (USD, millions)

Capital Expenditures (USD, millions)

Proceeds from / Repayments of Debt (USD, millions)

Share Repurchases (USD, millions)

Dividend Payments (USD, millions)

Net Change in Cash (USD, millions)

5d84c9f297884494d17f3abb9b4bd73b3cb3da547765417424fb1ab4ca70569b

c1746db4872792c6a200197b9594b79a690c7bfec52ab7059389af53a1df9672

c3e0ee5e9b0389872f328c6bc9e1bed204e8cb6cbbadf47df00225d4c1f4babd

Net income (USD, millions)

Depreciation (USD, millions)

Amortization of intangible assets (USD, millions)

Indefinite-lived intangible asset impairment (USD, millions)

Stock-based compensation expense (USD, millions)

Stock based compensation expense (USD, millions)

Other non-cash expense (USD, millions)

Changes in operating assets and liabilities, net of acquisitions: (USD, millions)

Net cash provided by operating activities (USD, millions)

Capital expenditures (USD, millions)

Cash received on derivative contracts (USD, millions)

Cash paid on derivative contracts (USD, millions)

Proceeds from sale of property, plant and equipment (USD, millions)

Net cash used in investing activities (USD, millions)

Proceeds on short-term borrowings (USD, millions)

Net borrowings (repayments) on short-term borrowings (USD, millions)

Cash dividends paid (USD, millions)

Repayments on long-term borrowings (USD, millions)

Other financing activities, net (USD, millions)

Net cash (used in) provided by financing activities (USD, millions)

Effect of exchange rate changes on cash and cash equivalents (USD, millions)

Net (decrease) increase in cash and cash equivalents (USD, millions)

Interest paid, net of amounts capitalized (USD, millions)

Change in accounts payable related to capital expenditures (USD, millions)

Deferred income taxes (USD, millions)

Cash and cash equivalents at beginning of period (USD, millions)

Cash and cash equivalents at end of period (USD, millions)

a3c7c3d1622e65d79e446d269231e24bbb5b649be07c55655da01aa9557bef2a

Net sales (USD, millions)

Cost of products sold (USD, millions)

Gross profit (USD, millions)

Selling, general, and administrative expenses (USD, millions)

Research and development expenses (USD, millions)

Intangible asset impairments (USD, millions)

Restructuring and other costs (USD, millions)

Operating (loss) income (USD, millions)

Interest expense, net (USD, millions)

Other (income) expense, net (USD, millions)

Loss (income) before income taxes (USD, millions)

Provision (benefit) for income taxes (USD, millions)

Net (loss) income (USD, millions)

Net loss attributable to noncontrolling interests (USD, millions)

Net (loss) income attributable to Dentsply Sirona (USD, millions)

Basic (loss) income per common share attributable to Dentsply Sirona (USD)

Diluted (loss) income per common share attributable to Dentsply Sirona (USD)

Basic weighted average common shares outstanding (Millions)

Diluted weighted average common shares outstanding (Millions)

9516f9604c569ad8c16878094aec9b2f9921f05cfe17c50aea4acb682d360be2

Cash and Cash Equivalents (USD, millions)

Accounts and Notes Receivable-Trade, Net (USD, millions)

Inventories, Net (USD, millions)

Prepaid Expenses and Other Current Assets (USD, millions)

Total Current Assets (USD, millions)

Property, Plant, and Equipment, Net (USD, millions)

Operating Lease Right-of-Use Assets, Net (USD, millions)

Identifiable Intangible Assets, Net (USD, millions)

Goodwill (USD, millions)

Other Noncurrent Assets (USD, millions)

Total Assets (USD, millions)

Accounts Payable (USD, millions)

Accrued Liabilities (USD, millions)

Income Taxes Payable (USD, millions)

Notes Payable and Current Portion of Long-Term Debt (USD, millions)

Total Current Liabilities (USD, millions)

Long-Term Debt (USD, millions)

Operating Lease Liabilities (USD, millions)

Deferred Income Taxes (USD, millions)

Other Noncurrent Liabilities (USD, millions)

Total Liabilities (USD, millions)

Common Stock (USD, millions)

Capital in Excess of Par Value (USD, millions)

(Accumulated Deficit) Retained Earnings (USD, millions)

Accumulated Other Comprehensive Loss (USD, millions)

Treasury Stock, at Cost (USD, millions)

Total Dentsply Sirona Equity (USD, millions)

Noncontrolling Interests (USD, millions)

Total Equity (USD, millions)

Total Liabilities and Equity (USD, millions)

679f38bfd12c0cc35a064593c0870ca95ac00269fb365596763452c25dcdc61c

99c72ee07e5b2b674f183e14eb3c818448c7d992364507908a44b941a4c93b16

United States

- Germany

Europe

Rest of World

Other Foreign

Total Revenue

d0148873223d606f2987a2fbccfe786b5f2829f8395e3e9874ee81ae92a78cc2

DENTSPLY SIRONA Inc (XRAY)

Financials